198 related articles for article (PubMed ID: 15372212)
1. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
Nordberg A
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1540-3. PubMed ID: 15372212
[No Abstract] [Full Text] [Related]
2. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
Hardy J
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1539-40. PubMed ID: 15372211
[No Abstract] [Full Text] [Related]
3. Picture imperfect: Going beyond imaging amyloid in Alzheimer's disease.
Kincaid E
Nat Med; 2016 Oct; 22(10):1067-1068. PubMed ID: 27711060
[No Abstract] [Full Text] [Related]
4. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
Villemagne VL; Rowe CC
J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
[TBL] [Abstract][Full Text] [Related]
5. 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.
Kung HF; Choi SR; Qu W; Zhang W; Skovronsky D
J Med Chem; 2010 Feb; 53(3):933-41. PubMed ID: 19845387
[No Abstract] [Full Text] [Related]
6. [Amyloid-plaque imaging of the brain using PET].
Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN
Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182
[TBL] [Abstract][Full Text] [Related]
7. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
[TBL] [Abstract][Full Text] [Related]
8. [The contribution of nuclear medicine procedures in the diagnosis of dementia of Alzheimer's type. Imaging beta amyloid plaques].
Tsolaki M; Trontzos C; Kazis A
Hell J Nucl Med; 2005; 8(3):187-90. PubMed ID: 16390030
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in imaging Alzheimer's disease.
Braskie MN; Toga AW; Thompson PM
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S313-27. PubMed ID: 22672880
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease.
Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF
Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502
[TBL] [Abstract][Full Text] [Related]
11. Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twist.
Klunk WE
Arch Neurol; 2008 Oct; 65(10):1281-3. PubMed ID: 18852340
[No Abstract] [Full Text] [Related]
12. Beta amyloid imaging with positron emission tomography (PET) for evaluation of suspected Alzheimer's disease or other causes of cognitive decline.
Technol Eval Cent Assess Program Exec Summ; 2013 Feb; 27(5):1-4. PubMed ID: 23589929
[No Abstract] [Full Text] [Related]
13. New IDEAS Amyloid Imaging 2021 Study: Running in Place with Ineffective Anti-Amyloid Treatments for Alzheimer's Disease Patients.
Barrio JR; Whitehouse P; Alavi A; Høilund-Carlsen PF
J Alzheimers Dis; 2021; 82(2):461-462. PubMed ID: 34024842
[No Abstract] [Full Text] [Related]
14. Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography.
Klunk WE; Engler H; Nordberg A; Bacskai BJ; Wang Y; Price JC; Bergström M; Hyman BT; Långström B; Mathis CA
Neuroimaging Clin N Am; 2003 Nov; 13(4):781-9, ix. PubMed ID: 15024961
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
Lee I; Yang J; Lee JH; Choe YS
Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
[TBL] [Abstract][Full Text] [Related]
16. Advances in Aβ plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease.
Jovalekic A; Bullich S; Catafau A; de Santi S
Neurodegener Dis Manag; 2016 Dec; 6(6):491-497. PubMed ID: 27813444
[TBL] [Abstract][Full Text] [Related]
17. Slow walking speed may be early sign of Alzheimer's in older people, study finds.
Mayor S
BMJ; 2015 Dec; 351():h6506. PubMed ID: 26634380
[No Abstract] [Full Text] [Related]
18. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.
Huddleston DE; Small SA
Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505
[TBL] [Abstract][Full Text] [Related]
19. Radioiodinated benzimidazole derivatives as single photon emission computed tomography probes for imaging of β-amyloid plaques in Alzheimer's disease.
Cui M; Ono M; Kimura H; Kawashima H; Liu BL; Saji H
Nucl Med Biol; 2011 Apr; 38(3):313-20. PubMed ID: 21492779
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for β-amyloid plaques in Alzheimer's brains.
Cheng Y; Ono M; Kimura H; Ueda M; Saji H
J Med Chem; 2012 Mar; 55(5):2279-86. PubMed ID: 22364445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
